Article
Real‐time longitudinal analysis of human gliomas reveals in vivo genome evolution and therapeutic impact under standardized treatment
1 Jul 2022
Abstract excerpt
The molecular characterization of glioma genes is essential for properly managing and treating this heterogeneous disease.1, 2 However, the true in vivo evolution of the genome of glioma patients during treatment and its impact on clinical outcomes is unclear.3 Here, we have performed an in-depth analysis of ctDNA from patients’ tumour in situ fluid (TISF)4 samples at baseline (BL), disease progression, and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
